AbbVie to Present at the Leerink Partners Global Healthcare Conference
Tuesday, March 3, 2026 1 min read
Key Takeaway: AbbVie will participate in the Leerink Partners Global Healthcare Conference on March 10, 2026. The management team will engage in a fireside chat at 10:20 a.m. Central Time, which will be available via a live audio webcast. An archived version of the session will also be accessible later that day.
Price reaction · baseline $234.26 (2026-03-02 close) · hit pre-market · 1 other ABBV headline(s) in the window, move may be shared
day 0 close
-0.2%
Market Sentiment Analysis
POSITIVE FACTORS
AbbVie is actively engaging with investors at a major healthcare conference.
The presentation will be accessible via a live audio webcast.
AbbVie aims to address significant health challenges through innovation.
Full Press Release Details
NORTH CHICAGO, Ill.,March 3, 2026/PRNewswire/ -- AbbVie (NYSE:ABBV) will participate in the Leerink Partners Global Healthcare Conference on Tuesday, March 10, 2026. Management will participate in a fireside chat at 10:20 a.m. Central Time.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website atinvestors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us atwww.abbvie.com. Follow @abbvie onLinkedIn,Facebook,Instagram,XandYouTube.